Advertisement

Topics

Abeona Therapeutics Inc: Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA

08:52 EST 9 Nov 2017 | FinanzNachrichten

-- Company Opens European Subsidiary in Spain to Support Global Clinical Development -- Nine subjects at global clinical sites enrolled to date with more than 2,000 days cumulative follow up assess...

Original Article: Abeona Therapeutics Inc: Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA

NEXT ARTICLE

More From BioPortfolio on "Abeona Therapeutics Inc: Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA"

Advertisement
Quick Search
Advertisement
Advertisement